ad

Mardia Samyoung Capillary Tubes Co Q2 Results FY27: Profit Rises 4,800% YoY, Revenue Rs 23.38 Cr, PAT Rs 0.98 Cr

26 Oct 2026 • 9:58 pm

Mardia Samyoung Capillary Tubes Co Q2 Results FY27: Profit Rises 4,800% YoY, Revenue Rs 23.38 Cr, PAT Rs 0.98 Cr

Quick Answer

Mardia Samyoung Capillary Tubes Co Q2 Results FY27 were declared on 26 October 2026 on a standalone basis. Revenue reached Rs 23.38 Cr against Rs 0.41 Cr a year earlier, a YoY growth of 5,602.44%, while net profit rose to Rs 0.98 Cr from Rs 0.02 Cr, up 4,800%. The quarterly results cover July to September 2026 and are summarised below, with the full analysis following in the sections after the table.

Mardia Samyoung Capillary Tubes Co Ltd (MSCTC) Q2 Results FY27 announced on 26 October 2026, covering the company's financial performance for the July to September quarter. Mardia Samyoung Capillary Tubes Co Q2 Results FY27 record revenue of Rs 23.38 Cr and PAT of Rs 0.98 Cr on a standalone basis. Standalone results and the results date both frame the comparison, which runs against the same quarter of last year.

This Univest Mardia Samyoung Capillary Tubes Co Q2 Results results analysis covers the financial highlights, the business drivers, the FY27 outlook and the risks to watch, and it begins with the Financial Highlights table that sets out each reported figure.

Click Here – Get Free Investment Predictions

Table of Contents

Mardia Samyoung Capillary Tubes Co Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 23.38 Cr Rs 0.41 Cr +5602.44% YoY
Operating Profit Rs 1.29 Cr Rs 0.02 Cr +6350% YoY
Net Profit (PAT) Rs 0.98 Cr Rs 0.02 Cr +4800% YoY

Source: company filing for Mardia Samyoung Capillary Tubes Co Q2 Results FY27, 26 October 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Mardia Samyoung Capillary Tubes Co Q2 Results: What Stands Out

  • Revenue of Rs 23.38 Cr compares with Rs 0.41 Cr in the same quarter last year, a YoY growth of 5,602.44% on the standalone figures.
  • Net profit of Rs 0.98 Cr compares with Rs 0.02 Cr a year earlier, a rise of 4,800% across the same two quarters.
  • Operating Profit of Rs 1.29 Cr compares with Rs 0.02 Cr in the prior-year quarter, a change of 6,350% on the standalone numbers.
  • Sequential figures show revenue down 5.9% from Rs 24.84 Cr and net profit down 6.7% from Rs 1.05 Cr in the previous quarter.
  • Next, the performance analysis of Mardia Samyoung Capillary Tubes Co Q2 Results FY27 tests how these YoY growth figures were built.

Mardia Samyoung Capillary Tubes Co Q2 Results FY27: Performance Analysis

The standalone numbers show a sharp rise in scale. Revenue moved from Rs 0.41 Cr to Rs 23.38 Cr, while net profit moved from Rs 0.02 Cr to Rs 0.98 Cr, so both lines grew by several thousand percent YoY. That is the core message of the quarterly results for July to September 2026.

The Mardia Samyoung Capillary Tubes Co Q2 Results FY27 figures also show Operating Profit of Rs 1.29 Cr against Rs 0.02 Cr last year, a rise of 6,350%. Net profit of Rs 0.98 Cr sits below the Operating Profit figure, so the two lines are read together in this results analysis, with revenue as the base for both.

Revenue of Rs 0.41 Cr in the same quarter last year is the comparison base for every YoY growth figure in Mardia Samyoung Capillary Tubes Co Q2 Results FY27. The Mardia Samyoung Capillary Tubes Co Q2 Results data confirms the results but does not establish the specific cause of the change, so the disclosed drivers are reported next, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points first to revenue, which grew 5,602.4% year on year to Rs 23.38 Cr in the latest quarter, as recorded in the supplied quarterly results data for the standalone business.

Net Profit Growth – Net profit rose 4,800.0% year on year to Rs 0.98 Cr in Mardia Samyoung Capillary Tubes Co Q2 Results FY27. The supplied data records the increase but does not give a disclosed reason for it, so no cause is assigned here.

Return Ratios – Return on equity was 158.95% and return on capital employed was 102.52% in FY25. These are ratios for the earlier financial year and are shown as reported, not as a forecast for FY27.

FY27 Outlook After Mardia Samyoung Capillary Tubes Co Q2 Results

FY27 full-year results will depend on the quarters still to be reported and on the conditions the company discloses. Net profit of Rs 0.98 Cr in the July to September quarter follows net profit of Rs 1.05 Cr in the previous quarter, and both are inputs into the full-year picture.

This results analysis therefore treats the Mardia Samyoung Capillary Tubes Co Q2 Results FY27 numbers as a single checkpoint rather than a projection. Investors tracking the next quarterly figures on the Univest app can compare revenue against Rs 23.38 Cr and net profit against Rs 0.98 Cr, and the risks that affect those comparisons come next.

Key Risks to Watch After Mardia Samyoung Capillary Tubes Co Q2 Results FY27

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 0.02 Cr to Rs 1.29 Cr over the last five quarters, so the YoY growth in the latest quarter sits within a wide quarterly range.

Revenue Below the Previous Quarter

Revenue was down 5.9% quarter on quarter from Rs 24.84 Cr to Rs 23.38 Cr, so Mardia Samyoung Capillary Tubes Co Q2 Results FY27 shows a sequential dip even though the year on year comparison is far higher.

Net Profit Below the Previous Quarter

Net profit was down 6.7% quarter on quarter from Rs 1.05 Cr, which leaves the latest figure of Rs 0.98 Cr below the previous quarter's level and below the Operating Profit of Rs 1.29 Cr.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Mardia Samyoung Capillary Tubes Co Q2 Results FY27 record standalone revenue of Rs 23.38 Cr and net profit of Rs 0.98 Cr for July to September 2026. These quarterly results show large YoY gains alongside a sequential dip from the previous quarter. Readers can compare the Mardia Samyoung Capillary Tubes Co Q2 Results standalone results with the full filing, and should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Mardia Samyoung Capillary Tubes Co Q2 Results FY27

What are Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Mardia Samyoung Capillary Tubes Co Q2 Results FY27 are the standalone results declared on 26 October 2026, with revenue of Rs 23.38 Cr and net profit of Rs 0.98 Cr. Alongside this, the Financial Highlights table lists each figure.

What is the results date for Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. The results date for Mardia Samyoung Capillary Tubes Co Q2 Results FY27 is 26 October 2026, covering the July to September 2026 standalone results. This matches the date given in the Quick Answer and the opening section.

What revenue was reported in Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Mardia Samyoung Capillary Tubes Co reported revenue of Rs 23.38 Cr in Q2 FY27 against Rs 0.41 Cr a year earlier, while the Financial Highlights table shows the full YoY comparison.

What net profit was reported in Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Net profit in Mardia Samyoung Capillary Tubes Co Q2 Results FY27 was Rs 0.98 Cr against Rs 0.02 Cr a year earlier, so net profit grew 4,800%, as set out in the Key Takeaways section.

How much YoY growth did revenue show in Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Revenue in Mardia Samyoung Capillary Tubes Co Q2 Results FY27 grew 5,602.44% YoY, from Rs 0.41 Cr to Rs 23.38 Cr, while the Performance Analysis section explains the comparison with the same quarter last year.

Did net profit rise or fall in Mardia Samyoung Capillary Tubes Co Q2 Results?

Ans. Mardia Samyoung Capillary Tubes Co Q2 Results show net profit rising to Rs 0.98 Cr from Rs 0.02 Cr YoY, while it was down 6.7% from the previous quarter, as covered under Key Risks.

What was the Operating Profit in Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Operating Profit in Mardia Samyoung Capillary Tubes Co Q2 Results FY27 was Rs 1.29 Cr against Rs 0.02 Cr a year earlier, a rise of 6,350%, so it is listed in the Financial Highlights table.

Are Mardia Samyoung Capillary Tubes Co Q2 Results consolidated results or standalone results?

Ans. Mardia Samyoung Capillary Tubes Co Q2 Results are standalone results, as supplied with the filing declared on 26 October 2026. Alongside this, every figure in the article uses the standalone basis.

What business factors shaped Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. The supplied factors are revenue growth of 5,602.4% YoY, net profit growth of 4,800.0% YoY and FY25 return on equity of 158.95%, so the Key Business Factors section lists each of them.

What are the key risks after Mardia Samyoung Capillary Tubes Co Q2 Results FY27?

Ans. Key risks after Mardia Samyoung Capillary Tubes Co Q2 Results FY27 are volatile quarterly net profit, revenue down 5.9% from the previous quarter and net profit down 6.7%, so the Key Risks section lists all three.

What is the outlook after Mardia Samyoung Capillary Tubes Co Q2 Results?

Ans. After Mardia Samyoung Capillary Tubes Co Q2 Results, FY27 full-year results will depend on the quarters still to be reported, while the Outlook section uses net profit of Rs 0.98 Cr as a checkpoint.

Where can I find the complete Mardia Samyoung Capillary Tubes Co Q2 Results FY27 data?

Ans. The complete Mardia Samyoung Capillary Tubes Co Q2 Results FY27 data is in the Financial Highlights table, so the Univest Screener can be used for further checks while the results analysis explains each figure.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down